brand logo

Am Fam Physician. 2023;107(3):303-304

Author disclosure: No relevant financial relationships.

Adnexal and ovarian masses (including cysts) are common and may require surgery. The U.S. Food and Drug Administration has approved the Risk of Ovarian Malignancy Algorithm (ROMA) test to assess the presurgical likelihood of ovarian cancer in an adult with an ovarian mass for whom surgery is planned. This test combines two serologic biomarkers (human epididymis protein 4 and cancer antigen 125) with menopausal status to produce a numerical score that identifies patients as having low or high risk. Two other multimarker serum tests (OVA1 and Overa), each of which checks for five serum markers, have also been approved by the U.S. Food and Drug Administration for the same indication.

The American College of Obstetricians and Gynecologists recommends that the risk of malignancy be evaluated before surgery because outcomes are improved when patients with cancer have surgery performed by a gynecologic oncologist.1

ROMAAssesses likelihood of ovarian cancer in patients with planned surgeryPatients older than 18 years with an adnexal mass who have not yet been referred to an oncologist$260
Already a member/subscriber?  Log In


From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available

Issue Access

  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

This series is coordinated by Natasha Pyzocha, DO, contributing editor.

A collection of Diagnostic Tests published in AFP is available at

Continue Reading

More in AFP

More in PubMed

Copyright © 2023 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.